Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease

Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease

Abstract Enzyme replacement therapy (ERT) is a mainstay of treatment for Anderson–Fabry disease (AFD), a pathology with negative effects on the heart and kidneys. However, no reliable biomarkers are available to monitor its efficacy. Therefore, we tested a panel of four microRNAs linked with cardiac...

Full description

Bibliographic Details
Main Authors: Irene Salamon, Elena Biagini, Paolo Kunderfranco, Roberta Roncarati, Manuela Ferracin, Nevio Taglieri, Elena Nardi, Noemi Laprovitera, Luciana Tomasi, Marisa Santostefano, Raffaello Ditaranto, Giovanni Vitale, Elena Cavarretta, Antonio Pisani, Eleonora Riccio, Valeria Aiello, Irene Capelli, Gaetano La Manna, Nazzareno Galiè, Letizia Spinelli, Gianluigi Condorelli
Format: Article
Language:English
Published: Nature Publishing Group 2021-12-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-021-04438-5

Internet

https://doi.org/10.1038/s41419-021-04438-5

Similar Items